Knights of Columbus Asset Advisors LLC Buys New Position in Amrize Ltd $AMRZ

Knights of Columbus Asset Advisors LLC purchased a new position in Amrize Ltd (NYSE:AMRZFree Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 25,076 shares of the company’s stock, valued at approximately $1,217,000.

Several other large investors also recently bought and sold shares of AMRZ. Global Retirement Partners LLC purchased a new stake in shares of Amrize during the third quarter valued at approximately $48,000. BNP Paribas Financial Markets acquired a new stake in Amrize during the 2nd quarter valued at $59,000. Groupe la Francaise acquired a new stake in Amrize during the 2nd quarter valued at $60,000. Allianz SE purchased a new stake in Amrize during the 2nd quarter worth $80,000. Finally, Osaic Holdings Inc. acquired a new position in Amrize in the 2nd quarter worth $90,000.

Amrize Trading Down 2.8%

Shares of NYSE AMRZ opened at $52.64 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The company has a market cap of $29.11 billion and a P/E ratio of 28.61. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $58.11. The firm has a 50 day moving average price of $54.24.

Analysts Set New Price Targets

AMRZ has been the topic of a number of analyst reports. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. Royal Bank Of Canada downgraded Amrize from an “outperform” rating to a “sector perform” rating and lifted their price objective for the stock from $56.00 to $60.00 in a report on Monday, December 8th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $70.00 target price on shares of Amrize in a research report on Thursday, December 18th. Weiss Ratings downgraded shares of Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Finally, Zacks Research upgraded shares of Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and an average target price of $60.75.

View Our Latest Stock Report on AMRZ

Insider Buying and Selling at Amrize

In other Amrize news, insider Jaime Hill bought 4,000 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were bought at an average cost of $50.69 per share, with a total value of $202,760.00. Following the completion of the acquisition, the insider owned 18,101 shares of the company’s stock, valued at approximately $917,539.69. This trade represents a 28.37% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nicholas C. Gangestad purchased 2,000 shares of Amrize stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the completion of the transaction, the director owned 4,958 shares in the company, valued at approximately $234,711.72. The trade was a 67.61% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.